期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
社区获得性肺炎的非典型病原体及治疗
1
作者 Kristopher P.Thibodeau +7 位作者 Anthony j.viera Naval Hospital Jacksonville JacksonvilleFlorida 《中国实用乡村医生杂志》编辑部 康素明 《中国实用乡村医生杂志》 2005年第12期52-53,共2页
每年社区获得性肺炎影响大约450万美国成年人.患社区获得性肺炎的住院患者的病死率每年不同,最高可达35%.肺炎链球菌可导致70%的社区获得性肺炎的病例,而非典型病原体导致30%~40%的病例.尽管我们已经获知有关非典型病原体导致感染的特... 每年社区获得性肺炎影响大约450万美国成年人.患社区获得性肺炎的住院患者的病死率每年不同,最高可达35%.肺炎链球菌可导致70%的社区获得性肺炎的病例,而非典型病原体导致30%~40%的病例.尽管我们已经获知有关非典型病原体导致感染的特征,但是在临床、放射学、检验学基础上确定某种特定的病原体非常困难.确定病原体通常是回顾性的. 展开更多
关键词 肺炎 社区获得性 非典型病原体 治疗
暂未订购
Deposition chamber technology as building blocks for a standardized brain-on-chip framework
2
作者 B.G C Maisonneuve L.Libralesso +9 位作者 L.Miny A.Batut J.Rontard M.Gleyzes B.Boudra j.viera D.Debis F.Larramendy V.Jost T.Honegger 《Microsystems & Nanoengineering》 SCIE EI CSCD 2022年第4期151-164,共14页
The in vitro modeling of human brain connectomes is key to exploring the structure-function relationship of the central nervous system.Elucidating this intricate relationship will allow better studying of the patholog... The in vitro modeling of human brain connectomes is key to exploring the structure-function relationship of the central nervous system.Elucidating this intricate relationship will allow better studying of the pathological mechanisms of neurodegeneration and hence result in improved drug screenings for complex neurological disorders,such as Alzheimer’s and Parkinson diseases.However,currently used in vitro modeling technologies lack the potential to mimic physiologically relevant neural structures.Herein,we present an innovative microfluidic design that overcomes one of the current limitations of in vitro brain models:their inability to recapitulate the heterogeneity of brain regions in terms of cellular density and number.This device allows the controlled and uniform deposition of any cellular population within unique plating chambers of variable size and shape.Through the fine tuning of the hydrodynamic resistance and cell deposition rate,the number of neurons seeded in each plating chamber can be tailored from a thousand up to a million.By applying our design to so-called neurofluidic devices,we offer novel neuro-engineered microfluidic platforms that can be strategically used as organ-on-a-chip platforms for neuroscience research.These advances provide essential enhancements to in vitro platforms in the quest to provide structural architectures that support models for investigating human neurodegenerative diseases. 展开更多
关键词 ARCHITECTURES OVERCOME hence
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部